Home › Lab Tests › Noninvasive prenatal testing (Nipt) Test
₹18,999₹21,000 10% off
Non-invasive prenatal testing (NIPT) is a screening test done on the mother's blood during pregnancy. It analyses small fragments of the baby's DNA from the placenta that circulate in the mother's blood, to estimate the chance of Down syndrome (trisomy 21), Edwards syndrome (trisomy 18) and Patau syndrome (trisomy 13). It can be done from 10 weeks of pregnancy and carries no risk to the baby, but a high-chance result needs to be confirmed by a diagnostic test.
No fasting required. The test can be done after 10 completed weeks of pregnancy; carry your latest ultrasound report and doctor's prescription.
It is done to estimate the chance that the baby has certain chromosomal conditions, mainly Down syndrome, Edwards syndrome and Patau syndrome. It detects these more accurately than the double, triple or quadruple marker tests, and helps parents and doctors decide whether a diagnostic test is needed.
Any pregnant woman from 10 weeks onwards may choose it after counselling. Doctors often advise it for women aged 35 or above, those with a higher-chance result on a marker test, certain ultrasound findings, or a previous pregnancy or family history of a chromosomal condition.
No fasting is needed and you can take your usual medicines. You must have completed 10 weeks of pregnancy, confirmed by ultrasound. Carry your latest ultrasound report and doctor's prescription, and tell the staff if the pregnancy is by IVF or donor egg, if there are twins, or if you have had a transfusion or transplant. You will be asked to sign a consent form.
A blood sample is drawn from a vein in the mother's arm into special tubes. It takes a few minutes and there is no risk to the baby. Your pregnancy details are recorded on a form, as they are needed to analyse and report the test.
No. NIPT is a very accurate screening test, but it can give false-positive and false-negative results. A high-chance result should be confirmed by a diagnostic test such as chorionic villus sampling or amniocentesis before any decision is made. A low-chance result is reassuring but does not replace your routine scans.
No. In India it is against the law to disclose the sex of an unborn baby, so the report does not mention it. The test is reported only for the chromosomal conditions it screens for.